GAMMA Investing LLC Buys Shares of 1,572 UiPath Inc. (NYSE:PATH)

GAMMA Investing LLC purchased a new position in shares of UiPath Inc. (NYSE:PATH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 1,572 shares of the healthcare company’s stock, valued at approximately $36,000.

A number of other hedge funds also recently modified their holdings of PATH. HighMark Wealth Management LLC purchased a new stake in UiPath in the fourth quarter worth $27,000. Fifth Third Bancorp raised its stake in UiPath by 2,005.3% in the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock valued at $34,000 after acquiring an additional 1,905 shares during the period. FNY Investment Advisers LLC bought a new stake in UiPath in the 4th quarter valued at about $40,000. FSC Wealth Advisors LLC purchased a new stake in UiPath during the fourth quarter valued at about $43,000. Finally, Tennessee Valley Asset Management Partners bought a new position in UiPath during the fourth quarter worth about $50,000. Institutional investors own 62.50% of the company’s stock.

UiPath Price Performance

Shares of NYSE:PATH opened at $19.48 on Friday. UiPath Inc. has a one year low of $12.38 and a one year high of $27.87. The company’s fifty day moving average price is $21.75 and its 200-day moving average price is $21.65.

UiPath (NYSE:PATH) last released its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The business had revenue of $405.25 million for the quarter, compared to analysts’ expectations of $383.32 million. Equities research analysts predict that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Buying and Selling

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the transaction, the chief financial officer now directly owns 660,762 shares in the company, valued at $14,312,104.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold 72,000 shares of company stock worth $1,591,360 in the last quarter. 31.03% of the stock is owned by insiders.

Analysts Set New Price Targets

PATH has been the topic of a number of recent research reports. DA Davidson upped their price target on shares of UiPath from $20.00 to $24.00 and gave the company a “neutral” rating in a research note on Thursday, March 14th. Wells Fargo & Company raised their price target on UiPath from $24.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, March 14th. KeyCorp started coverage on UiPath in a research note on Monday, April 8th. They set an “overweight” rating and a $27.00 price objective on the stock. Bank of America raised their target price on UiPath from $26.00 to $30.00 and gave the stock a “buy” rating in a research note on Thursday, March 14th. Finally, Mizuho upped their price target on UiPath from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Thursday, March 14th. Nine equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $27.41.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.